Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live ...

Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.

Immune cells called regulatory T cells have long been known for their role in countering inflammation. In the setting of ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...

Yescarta continued to demonstrate durable responses after a median follow-up of more than five years in patients with R/R ...